Skip to main content
Premium Trial:

Request an Annual Quote

Cellumen and RheoGene Enter Into Non-Exclusive Licensing Deal

NEW YORK, Aug. 1 (GenomeWeb News) - Cellumen and RheoGene announced last week that they have entered into a non-exclusive commercial licensing agreement under which Cellumen will use RheoGene's RheoSwitch inducible gene regulation technology to develop cell biology screening products.

 

The products will include reagents for high content screening and stable cell lines. In addition, the companies will collaborate on the development and validation of mammalian cell lines to be used in Cellumen's cell biology profiling assays.

 

Financial terms of the deal were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.